IN BRIEF: Oxford BioDynamics up on US reimbursement code for EpiSwitch
Oxford BioDynamics PLC - Oxford-based biotechnology firm focused on discovery and development of epigenetic biomarkers Says its US reimbursement code for EpiSwitch is now available. EpiSwitch Checkpoint-inhibitor Response Test is a test which predicts a patient's likely response to immune checkpoint inhibitor therapy. It was first launched in the US in February. Read More